The life sciences industry needs a shot of adrenaline. An aging population and a rise in chronic diseases are fueling the ...

Ten stocks took a beating on Wednesday, mimicking a mostly pessimistic broader market, as investors repositioned portfolios ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a clinical-stage biotechnology company integrating artificial intelligence ...

The U.S. is engaged in various activities from international deportation agreements to tackling AI-induced job fears. Notable developments include Google's $30 million settlement over YouTube's child ...

How to get rich? The single best way is to live a long time, ideally working much of that time while amassing savings that ...

Recent reports highlight uncertainty about pharmaceutical tariffs, an error-prone AI tool in use at the FDA, and research funding in jeopardy.

The Global Mass Spectrometry Market size valued at approximately USD 6.9 billion in 2024, is projected to reach USD 10.38 billion by 2030, growing at ...

With one year until new rules on ‘high-risk’ AI systems take effect in the EU, pharmaceutical companies using AI in the ...

As global director of healthcare and sciences at Google Cloud, Shweta Maniar is working with organizations to find ways to ...

Rob Abbott, CEO, ISPOR, highlights how AI is streamlining research and improving patient care while stressing the importance of human oversight.

Cell culture is a foundational technology widely used across fields such as pharmaceutical production, regenerative medicine, ...

Shares of specialty pharmaceutical company ANI Pharmaceuticals (NASDAQ:ANIP) jumped 18.4% in the morning session after the ...